Career Development

Career development of future researchers is a core focus of CREATE. The overall goal of career development is to identify and train investigators who will be future leaders in pulmonary fibrosis research.

Research training opportunities include:

• PhD scholarships for projects supervised by CRE-PF investigators
• Post-doctoral fellowships
• Collaboration grants-in-aid
• Travel grants 
• Symposia
• Monthly virtual research meetings
• Mentoring program

Grants are allocated via a competitive application process.

Current Funding Opportunities

CREATE Grants-in Aid for Collaborative Pulmonary Fibrosis Research

Two CREATE Grant-in-Aid each valued at up to $10,000 are offered to assist new collaborative investigator-led Pulmonary Fibrosis research within the group of CREATE Fellows. The objective is to encourage new research which meets the aims of the CRE-PF and builds collaborations between CREATE Fellows drawn together through the CRE-PF.

Applications close on June 3, 2024.

CREATE Grant in -Aid Application Form

PACT Grant-in Aid for Investigator-Led Pulmonary Fibrosis Clinical Research

2024 PACT Grant-in-Aid applications are now open! 

Applications open from Friday 12^th April until Sunday 2^nd June 2024.

Pease find further information about this opportunity and download the application form here.

CREATE Hope Fellowships in Pulmonary Fibrosis Research

An initiative of the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF), supported by Lung Foundation Australia's Hope Research Fund, the CREATE Hope Fellowships in Pulmonary Fibrosis support research into pulmonary fibrosis (PF) in Australia. 

The CRE-PF will allocate two Fellowships to early career researchers, each for $75,000, over the period of one year. Applications open approximately July 2024.

Past Funding Opportunities

2023 PACT Grant-in-Aid

The Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network offered a 2023 PACT Grant-in-Aid for Investigator Led Pulmonary Fibrosis Clinical Research in October 2023. 

The Grant-in-Aid valued at $30,000 was awarded to A/Prof Natasha Smallwood and Mrs Catherine Buchan, Alfred Health and Monash University, for the project "A phase II randomised crossover trial to assess feasibility of domiciliary Nasal high Flow for chronic breathlessNess in people with InTerstial lung disEase (INFINITE)".

Lung Foundation Australia Grants

Lung Foundation Australia funding opportunities for 2023 have now closed.

https://lungfoundation.com.au/research/awards-and-grants/apply-for-funding/

2022 PACT Grant-in-Aid

The Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network offered a 2022 PACT Grant-in-Aid for Investigator Led Pulmonary Fibrosis Clinical Research in April 2022. 

The Grant-in-Aid valued at $30,000 was awarded to Dr Hayley Barnes from Austin Health for "Discovering Radiological Biomarkers in Silicosis using Artificial Intelligence."

CREATE Hope Clinical Fellowship in Pulmonary Fibrosis (PF) Research

An initiative of the Centre for Research Excellence in Pulmonary Fibrosis, supported by Lung Foundation Australia’s Hope Research Fund. The CREATE Hope Clinical Fellowship in Pulmonary Fibrosis was offered in early 2022. This Fellowship was awarded to Dr Ingrid Cox from the Menzies Institute for Medical Research and University of Tasmania.

CREATE Hope Scientific Fellowship in Pulmonary Fibrosis (PF) Research

A CREATE Hope Scientific Fellowship in Pulmonary Fibrosis was offered in 2021 for commencement in 2022. This Fellowship was awarded to Dr Gang Liu from the University of Technology Sydney and the Centenary Institute.

CREATE Grants-in-Aid

In 2020 and 2021, CREATE Grants-in-Aid were offered to specifically support new collaborations for PF research amongst CREATE ECRs from two or more institutions. One grant was awarded in 2020 and two more in 2021.

• Dr Laura Glenn and Dr Alan Teoh, Royal Prince Alfred Hospital, Dr Hayley Barnes, Alfred Health and Dr John Mackintosh, Prince Charles Hospital for development of a standard framework for ILD multi-disciplinary research meetings.
• Dr Gang Liu, UTS, Dr Ashleigh Philip, Garvan Institute and Dr Laura Glenn, Royal Prince Alfred Hospital for development of a fingerprint of the proteins that are present in lung fibrosis.
• Dr Jade Jaffar, Monash and Dr Yet Khor, Austin Health for establishing a multi-pronged research program on the effects of hypoxaemia (low oxygen levels) and oxygen therapy in interstitial lung disease.

2021 PACT Grant-in-Aid

The Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network offered the second annual PACT Grant-in-Aid for Investigator-led Pulmonary Fibrosis Clinical Research in February 2021.

The Grant-in-Aid valued at $30,000 was awarded to Dr Yet Hong Khor from Austin Health to assist investigator led Pulmonary Fibrosis clinical research.

CREATE Hope PhD Scholarships for Pulmonary Fibrosis Research

Thanks to a donation from Lung Foundation Australia's Hope Research Fund, the CRE-PF and LFA offered two PhD scholarships for a new or ongoing student, each for $28,000 for the academic year 2021.

Congratulations to the winners of the CREATE Hope PhD scholarships: Joanna Lee (Self-management for pulmonary fibrosis: what does it mean and how might it help?) and Claudia Sim (Targeting fibrosis with relaxin – a new therapeutic strategy for IPF and silicosis), both from Monash University.